In this article, we take a look at the 3 best stocks under $20 according to billionaire Andreas Halvorsen’s Viking Global. If you want to see our detailed analysis of Andreas Halvorsen’s hedge fund performance, early life, and biography, go directly to 7 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global.
3. Talaris Therapeutics, Inc. (NASDAQ:TALS)
Stake Value of Viking Global: $48,324,000
Share Price: $14.87
Percentage of Viking Global’s 13F Portfolio: 0.14%
Number of Hedge Fund Holders: 16
Talaris Therapeutics, Inc. (NASDAQ:TALS) operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Talaris Therapeutics, Inc. (NASDAQ:TALS) was founded in 1988 and is headquartered in Louisville, Kentucky.
This June, Evercore ISI analyst Josh Schimmer initiated coverage of Talaris Therapeutics, Inc. (NASDAQ:TALS) with an Outperform rating and $35 price target.
According to Q2 filings, Mr. Halvorsen owns over 3.28 million shares of Talaris Therapeutics, Inc. (NASDAQ:TALS). This amounts to a total stake value of $48.3 million which covers an impressive 0.14% of the billionaire’s investment portfolio.
By the end of the second quarter of 2021, 16 hedge funds out of the 873 tracked by Insider Monkey held stakes in Talaris Therapeutics, Inc. (NASDAQ:TALS) worth more than $150.4 million.
2. Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Stake Value of Viking Global: $58,172,000
Share Price: $17.30
Percentage of Viking Global’s 13F Portfolio: 0.17%
Number of Hedge Fund Holders: 15
Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb-girdle muscular dystrophies. Edgewise Therapeutics, Inc. (NASDAQ:EWTX) develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. (NASDAQ:EWTX) was founded in 2017 and is headquartered in Boulder, Colorado.
In the second quarter of 2021, Wedbush analyst Laura Chico initiated coverage of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) with an Outperform rating and $38 price target.
As of the second quarter of 2021, Mr. Halvorsen has stakes worth more than $58 million in Edgewise Therapeutrics, Inc. (NASDAQ:EWTX). He owns over 2.72 million shares in the company which accounts for 0.17% of his 13F portfolio.
By the end of the second quarter of 2021, 15 hedge funds out of the 873 tracked by Insider Monkey held stakes in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) worth $688.6 million. This is compared to 16 positions in the first quarter with stakes of more than $1 billion.
1. ICICI Bank Limited (NYSE:IBN)
Stake Value of Viking Global: $360,312,000
Share Price: $18.88
Percentage of Viking Global’s 13F Portfolio: 1.09%
Number of Hedge Fund Holders: 28
ICICI Bank Limited (NYSE:IBN) provides various banking products and financial services in India and internationally. It operates through Retail Banking, Wholesale Banking, Treasury, Other Banking, Life insurance, General insurance, and other segments. ICICI Bank Limited (NYSE:IBN) was founded in 1955 and is headquartered in Mumbai, India.
ICICI Bank Limited (NYSE:IBN) is a new addition to billionaire Andreas Halvorsen’s investment portfolio. According to the latest 13F filings, Mr. Halvorsen owns over 21 million shares of ICICI Bank Limited (NYSE:IBN) which amounts to a stake value of $360.3 million.
By the end of the second quarter of 2021, 28 hedge funds out of the 873 tracked by Insider Monkey held stakes in ICICI Bank Limited (NYSE:IBN) worth $2.47 billion. This is compared to 31 positions in the first quarter with stakes of more than $1.90 billion.
See also 10 Best Stocks Under $10 to Buy Right Now and 10 Best Dividend Paying Stocks to Buy Under $50.
